Blood transfusions for iron deficiency anaemia: definitely time for a rethink!
J. Shortt,
J. Shortt
Transfusion Medicine Services, Australian Red Cross Blood Service
Haematology Unit, Alfred Pathology, Alfred HospitalMelbourne, Victoria, Australia
Search for more papers by this author M. F. Cole-Sinclair,
M. F. Cole-Sinclair
Haematology Unit, Alfred Pathology, Alfred HospitalMelbourne, Victoria, Australia
Search for more papers by this author M. Borosak,
M. Borosak
Transfusion Medicine Services, Australian Red Cross Blood Service
Search for more papers by this author E. M. Wood,
E. M. Wood
Transfusion Medicine Services, Australian Red Cross Blood Service
Search for more papers by this author
J. Shortt,
J. Shortt
Transfusion Medicine Services, Australian Red Cross Blood Service
Haematology Unit, Alfred Pathology, Alfred HospitalMelbourne, Victoria, Australia
Search for more papers by this author M. F. Cole-Sinclair,
M. F. Cole-Sinclair
Haematology Unit, Alfred Pathology, Alfred HospitalMelbourne, Victoria, Australia
Search for more papers by this author M. Borosak,
M. Borosak
Transfusion Medicine Services, Australian Red Cross Blood Service
Search for more papers by this author E. M. Wood,
E. M. Wood
Transfusion Medicine Services, Australian Red Cross Blood Service
Search for more papers by this author
First published: 27 March 2007
No abstract is available for this article.
References
- 1
Ahmad I,
Gibson PR.
Management of iron deficiency in patients admitted to hospital: time for a rethink of treatment principles.
Intern Med J
2006; 36: 347–54.
- 2
Goodnough LT,
Skikne B,
Brugnara C.
Erythropoietin, iron and erythropoiesis.
Blood
2000; 96: 823–33.
- 3
Clinical practice guidelines on the use of blood components, National Health and Medical Research Council/Australasian Society of Blood Transfusion, 2001. Available from URL: http://www.nhmrc.gov.au/publications/_files/cp78.pdf [Accessed 19 November 2006]
- 4
Seed CR,
Kiely P,
Keller AJ.
Residual risk of transfusion transmitted human immunodeficiency virus, hepatitis B virus, hepatitis C virus and human T lymphotrophic virus.
Intern Med J
2005; 35: 592–8.
